These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6255540)

  • 21. Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
    Mobacken H; Moberg S
    Dermatologica; 1986; 173(5):229-36. PubMed ID: 3100354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral antifungal agent effective even for widespread infections.
    Check WA
    JAMA; 1980 Nov; 244(18):2019-20. PubMed ID: 6253688
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results.
    Phillips P; Fetchick R; Weisman I; Foshee S; Graybill JR
    Rev Infect Dis; 1987; 9 Suppl 1():S87-93. PubMed ID: 3027852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
    Ahonen P; Myllärniemi S; Kahanpää A; Perheentupa J
    Acta Med Scand; 1986; 220(4):333-9. PubMed ID: 3541501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis.
    Negroni R; Robles AM; Arechavala A; Tuculet MA; Galimberti R
    Rev Infect Dis; 1980; 2(4):643-9. PubMed ID: 6255544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for the systemic mycoses: the prelude to ketoconazole.
    Utz JP
    Rev Infect Dis; 1980; 2(4):625-32. PubMed ID: 6255542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.
    Kennedy CT; Valdimarsson H; Hay RJ
    J R Soc Med; 1981 Feb; 74(2):158-62. PubMed ID: 6259351
    [No Abstract]   [Full Text] [Related]  

  • 28. Modified response to ketoconazole of Candida albicans from a treatment failure.
    Warnock DW; Johnson EM; Richardson MD; Vickers CF
    Lancet; 1983 Mar; 1(8325):642-3. PubMed ID: 6131314
    [No Abstract]   [Full Text] [Related]  

  • 29. Progressive disseminated histoplasmosis; favorable response to ketoconazole.
    Hawkins SS; Gregory DW; Alford RH
    Ann Intern Med; 1981 Oct; 95(4):446-9. PubMed ID: 6269475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
    Dismukes WE; Stamm AM; Graybill JR; Craven PC; Stevens DA; Stiller RL; Sarosi GA; Medoff G; Gregg CR; Gallis HA; Fields BT; Marier RL; Kerkering TA; Kaplowitz LG; Cloud G; Bowles C; Shadomy S
    Ann Intern Med; 1983 Jan; 98(1):13-20. PubMed ID: 6293361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
    Mobacken H; Lindholm L; Moberg S
    Acta Derm Venereol; 1987; 67(3):257-60. PubMed ID: 2442942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
    Daugaard K; Nielsen H; Schiodt M
    Tandlaegebladet; 1985 Oct; 89(18):674-8. PubMed ID: 3868177
    [No Abstract]   [Full Text] [Related]  

  • 33. Ketoconazole: a major innovation for treatment of fungal disease.
    Graybill JR; Drutz DJ; Murphy AL
    Ann Intern Med; 1980 Dec; 93(6):921-3. PubMed ID: 6255850
    [No Abstract]   [Full Text] [Related]  

  • 34. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer developments in therapy for endemic mycoses.
    Kauffman CA
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S28-32. PubMed ID: 7948568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current therapy of pulmonary and disseminated fungal diseases.
    Stamm AM; Dismukes WE
    Chest; 1983 Jun; 83(6):911-7. PubMed ID: 6303713
    [No Abstract]   [Full Text] [Related]  

  • 37. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral ketoconazole therapy of a case of pulmonary histoplasmosis].
    Zellweger JP
    Schweiz Med Wochenschr; 1981 Feb; 111(6):190-1. PubMed ID: 6261325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketoconazole in experimental candidosis.
    Thienpont D; Van Cutsem J; Borgers M
    Rev Infect Dis; 1980; 2(4):570-7. PubMed ID: 6255532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketoconazole treatment in superficial mycoses.
    Puiatti P; Cervetti O; Forte M; Zina G
    Drugs Exp Clin Res; 1986; 12(5):405-7. PubMed ID: 3720525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.